[1]PHANG JUANITA M，HARROP STEPHEN J，DUFF ANTHONY P，et al.Structural characterization suggests models for monomeric and dimeric forms of full-length ezrin［J］.Biochem J，2016，473(18):2763-2782.
[2]FEHON RICHARD G，MCCLATCHEY ANDREA I，BRETSCHER ANTHONY.Organizing the cell cortex:the role of ERM proteins［J］.Nat Rev Mol Cell Biol，2010，11(4):276-287.
[3]PELASEYED THAHER，VISWANATHA RAGHUVIR，SAUVANET CECILE，et al.Ezrin activation by LOK phosphorylation involves a PIP-dependent wedge mechanism［J］.Elife，2017(6):e22759.
[4]FLORIAN KLEMM，JOHANNA A JOYCE.Microenvironmental regulation of therapeutic response in cancer［J］.Trends in Cell Biology，2015，25(4):198-213.
[5]QUAIL DANIELA F，JOYCE JOHANNA A.Microenvironmental regulation of tumor progression and metastasis［J］.Nature Medicine，2013，19(11):1423-1437.
[6]BLAYLOCK RUSSELL L.Viruses and tumor cell microenvironment:A brief summary［J］.Surgical Neurology International，2019，10(160):1-9.
[7]张媛媛，黄涛，米立志．依赖于微环境的TGFβ信号［J］．中国生物化学与分子生物学报，2019，35(11):1183-1192.
ZHANG YY，HUANG T，MI LZ.Microenvironment dependent TGF β signal［J］.Chinese Journal of Biochemistry and Molecular Biology，2019，35(11):1183-1192.
[8]HINOJOSA LAURA SOTO，HOLST MANUEL，BAARLINK CHRISTIAN，et al.MRTF transcription and Ezrin-dependent plasma membrane blebbing are required for entotic invasion［J］.J Cell Biol，2017，216(10):3087-3095.
[9]丁语石，余苏云，王蔚，等．Ezrin的生物学功能及其对肿瘤转移的影响研究进展［J］．中国药理学通报，2019，35（12）1642-1646.
DING YS，YU SY，WANG W，et al.Advances in biological functions of Ezrin and its effects on tumor metastasis［J］.Chin Pharmacol Bull，2019，35(12):1642-1646.
[10]CHEN Y，WANG DM，GUO Z，et al.Rho kinase phosphorylation promotes ezrin-mediated metastasis in hepatocellular carcinoma［J］.Cancer Res，2011，71(5):1721-1729.
[11]YANG ZS，QIN WH，CHEN Y，et al.Cholesterol inhibits hepatocellular carcinoma invasion and metastasis by promoting CD44 localization in lipid rafts［J］.Cancer Lett，2018，429:66-77.
[12]WANG Y，JIANG SC，CAO ZL，et al.Detecting the location and significance of Ezrin protein expression in hepatocellular carcinoma［J］.Int J Clin Exp PATHOI,2018，11(1):248-254.
[13]PAN DB，WANG S，YE HL，et al.Ezrin expression in the primary hepatocellular carcinoma patients and associated with clinical，pathological characteristics［J］.J Cancer Res Ther，2016，12(8):291-294.
[14]PARK HYUNJIN，LEE YANGKYU，LEE KIRYANG，et al.Theclinicopathological significance of YAP/TAZ expression in hepatocellular carcinoma with relation to hypoxia and stemness［J］.Pathology & Oncology Research，2021，27:604600.
[15]DU S，SONG X，LI Y，et al.Celastrol inhibits ezrin-mediated migration of hepatocellular carcinoma cells［J］.Scientific Reports,2020，10(1):11273.
[16]HAGO AHMED MUSA，GAMALLAT YASER，MAHMOUD SALMA ABDI，et al.Ezrin expression is altered in mice lymphatic metastatic hepatocellular carcinoma and subcellular fractions upon Annexin 7 modulation in-vitro［J］.Biomed Pharmacother，2017，85:209-217.
[17] BAKHEET AHMED MUSA HAGO，MAHMOUD SALMA ABDI，HUANG YUHONG，et al.Ezrin as a possible diagnostic and/or prognostic biomarker in mice lymphatic metastatic hepatocellular carcinoma in vivo［J］.Biofactors，2017，43(5):662-672.
[18]GHAFFARI ABDI，HOSKIN VICTORIA，TURASHVILI GULISA，et al.Intravital imaging reveals systemic ezrin inhibition impedes cancer cell migration and lymph node metastasis in breast cancer［J］.Breast Cancer Res，2019，21(1):12.
[19] LORENTZEN ANNA，BECKER PAUL F，KOSLA JAN，et al.Single cell polarity in liquid phase facilitates tumour metastasis［J］.Nat Commun，2018，9(1):887.
[20] LI N，KONG JN，LIN ZH,et al.Ezrin promotes breast cancer progression by modulating AKT signals［J］.Br J Cancer，2019，120(7):703-713.
[21]SONG XY，WANG WJ，WANG HW，et al.Acetylation of ezrin regulates membrane-cytoskeletal interaction underlying CCL18-elicited cell migration［J］.J Mol Cell Biol，2019，12(6)，424-437.
[22]REYMOND NICOLAS，D'AGUA BARBARA BORDA，RIDLEY ANNE J.Crossing the endothelial barrier during metastasis［J］.Nat Rev Cancer，2013，13(12):858-870.
[23]FRESE JULIA，CHEN MICHELLE B，HEBRON KATIE E，et al.Epithelial-mesenchymal transition induces podocalyxin to promote extravasation via ezrin signaling［J］.Cell Rep，2018，24(4):962-972.
[24]MA G，HUANG HX，LI MH，et al.Plasma CCL5 promotes EMT-medicated epirubicin-resistance in locally advanced breast cancer［J］.Cancer Biomark，2018，22(3):405-415.
[25]HEMALATHA SREELATHA K，SENGODAN SATHEESH KUMAR，NADHAN REVATHY，et al.Brcal defective breast cancer cells induce in vitro transformation of cancer associated fibroblasts(CAFs)to metastasis associated fibroblasts(MAF)［J］.Sci Rep，2018，8(1):13903.
[26]KIKUCHI KYOKO，MCNAMARA KEELY MAY，MIKI YASUHIRO，et al.S100P and Ezrin promote trans-endothelial migration of triple negative breast cancer cells［J］.Cell Oncol(Dordr)，2019，42(1):67-80.
[27]YE S，XU YY，LI JH，et al.Prognostic role of GPER/Ezrin in triple-negative breast cancer is associated with menopausal status［J］.Endocr Connect，2019，8(6):661-671.
[28]JIN TF，JIN JC，LI XY，et al.Prognostic implications of ezrin and p9osphorylated ezrin expression in non-small cell lung cancer［J］.BMC Cancer，2014，14:191.
[29]ZHANG XL，LI GM，GUO YC，et al.Regulation of ezrin tension by S-nitrosylation mediates non-small cell lung cancer invasion and metastasis［J］.Theranostics，2019，9(9):2555-2571.
[30] ZHANG XL,RUAN QL,ZHAI YQ，et al.Baicalein inhibits non-small-cell lung cancer invasion and metastasis by reducing ezrin tension in inflammation microenvironment［J］.Cancer Sci,2020，111(10):3802-3812.
[31]WANG AM，LU C，NING Z，et al.Tumor-associated macrophages promote Ezrin phosphorylation-mediated epithelial-mesenchymal transition in lung adenocarcinoma through FUT4/LeY up-regulation［J］.Oncotarget，2017，8(17):28247-28259.
[32]MOODLEY SERISHA,LIAN ERIC Y,CRUPI MATHIEU JF，et al.RET isoform-specific interaction with scaffold protein Ezrin promotes cell migration and chemotaxis in lung adenocarcinoma［J］.Lung Cancer，2020，142:123-131.
[33]WANG YX,YANG Y,WANG XY，et al.Ezrin as a prognostic indicator regulates colon adenocarinoma progression through glycolysis［J］.J Gastroenterol Hepatol，2020,36(3):710-720.
[34]LI YR，LIN ZY，CHEN B，et al.Ezrin/NF-kB activation regulates epithelial-mesenchymal transition induced by EGF and promotes metastasis of colorectal cancer［J］.Biomed.Pharmacother，2017，92:140-148.
[35]HAASE G，GAVERT N，BRABLETZ T，et al.A point mutation in the extracellular domain of L1 blocks its capacity to confer metastasis in colon cancer cells via CD10［J］.Oncogene，2017，36(11):1597-1606.
[36]GAVERT NANCY，BEN-SHMUEL AMIR，LEMMON VANCE，et al.Nuclear factor-kappaB signaling and ezrin are essential for L1-mediated metastasis of colon cancer cells［J］.J Cell Sci，2010，123(12):2134-2142.
[37]BEN-SHMUEL A，SHVAB A，GAVERT N，et al.Global analysis of L1-transcriptomes identified IGFBP-2 as a target of ezrin and NF-κB signaling that promotes colon cancer progression［J］.Oncogene，2013，32(27):3220-3230.
[38]CHERIYAMUNDATH S,KUMAR ANMOL,GAVERT NANCY，et al.The collagen-modifying enzyme PLOD2 is induced and required during L1-mediated colon cancer progression［J］.Int J Mol Sci，2021，22(7):3552.
[39]QUAN CJ，SUN J，LIN ZH，et al.Ezrin promotes pancreatic cancer cell proliferation and invasion through activating the Akt/mTOR pathway and inducing YAP translocation［J］.Cancer Manag Res，2019，11:6553-6566.
[40] ZHOU JH，FENG YJ，TAO KT，et al.The expression and phosphorylation of ezrin and merlin in human pancreatic cancer［J］.Int J Oncol，2014，44(6):2059-2067.
[41]PENCHEV VESSELIN R，CHANG YU-TAI，BEGUM ASMA，et al.Ezrinpromotes stem cell properties in pancreatic ductal adenocarcinoma［J］.Mol Cancer Res，2019，17(4):929-936.
[42]PIAO JJ，LIU SS，XU YJ，et al.Ezrin protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas［J］.Exp Mol Pathol，2015，98(1):1-6.
[43]CHANG YT,PENG HY,HU CM，et al.Pancreatic cancer-derived small extracellular vesical Ezrin regulates macrophage polarization and promotes metastasis［J］.Am J Cancer Res,2020，10(1):12-37.
[44]CAO LL，XIE JW，LIN Y，et al.MiR-183 inhibits invasion of gastric cancer by targeting Ezrin［J］.Int J Clin Exp Pathol，2014，7(9):5582-5594.
[45]JIN JC，JIN TF，QUAN ML，et al.Ezrin overexpression predicts the poor prognosis of gastric adenocarcinoma［J］.Diagn Pathol，2012，7:135.
[46]LI L，WANG YY，ZHAO ZS，et al.Ezrin is associated with gastric cancer progression and prognosis［J］.Pathol Oncol Res，2011，17(4):909-915.
[47]FAN LL，CHEN DF，LAN CH，et al.Knockdown of ezrin via RNA interference suppresses Helicobacter pylori-enhanced invasion of gastric cancer cells［J］.Cancer Biol Ther，2011，11(8):746-752.
[48]LATHIKA LAKSHMI MOHAN，NAIR JAGATHNATH KRISHNA KUMARAPILLAI MOHANAN，SARITHA VALLIAMMA NEELAKANDAPILLA，et al.Role of phospho-ezrin in differentiating thyroid carcinoma［J］.Sci Rep，2019，9(1):6190.
[49]SIKORSKA JUSTYNA，GAWEL DAMIAN，DOMEK HANNA，et al.Podoplanin(PDPN)affects the invasiveness of thyroid carcinoma cells by inducing ezrin，radixin and moesin(E/R/M)phosphorylation in association with matrix metalloproteinases［J］.BMC Cancer，2019，19:85.
[50]TANG YY，SUN XZ，YU S，et al.Inhibition of Ezrin suppresses cell migration and invasion in human nasopharyngeal carcinoma［J］.Oncol Lett，2019，18(1):553-560.
[51] LIU P，YANG P，ZHANG Z，et al.Ezrin/NF-κB pathway regulates EGF-induced epithelial-mesenchymal transition(EMT)，metastasis，and progression of osteosarcoma［J］.Med Sci Monit，2018，24:2098-2108.
[52]LI Y,LIU M,YANG ST，et al.RGS12 is a novel tumor suppressor in osteosarcoma that inhibits YAP-TEAD1-Ezrin signaling［J］.Oncogene，2021，40(14):2553-2566.
[53]KIM BYUNG-CHUL,KIM JINGYU,KIM KANGSAN，et al.EZRIn preliminary radiogenomic evidence for the prediction of metastasis and chemotherapy response in pediatric patients with osteosarcoma using F-FDF PET/CT［J］.Cancers(Basel)，2021，13(11):2671.
[54]ZHANG YS，WANG GQ.MicroRNA-183 inhibits A375 human melanoma cell migration and invasion by targeting Ezrin and MMP-9［J］.Oncol Lett，2019，17(1):548-554.
[55]YAN H，SUN BM，ZHANG YY，et al.Upregulation of miR-183-5p is responsible for the promotion of apoptosis and inhibition of the epithelial-mesenchymal transition，proliferation，invasion and migration of human endometrial cancer cells by downregulating Ezrin［J］.Int J Mol Med，2018，42(5):2469-2480.
[56]TAKASAWA KUMI,TAKASAWA AKIRA,AKIMOTO TAISHI，et al.Regulatory roles of claudin-1 in cell adhesion and microvilli formation［J］.Biochem Biophys Res Commun，2021，565:36-42.
[57]TANG JY,FANG KH,LI C，et al.ARHGEF10Lpromotes cervical tumorigenesis via RhoA-mediated signaling［J］.Evid Based Complement Alternat Med，2021，2021:6683264.
[58]LI MJ,XIONG D,HUANG H，et al.Ezrin promotes the proliferation，migration，and invasion of ovarian cancer cells［J］.Biomed Environ Sci，2021，34(2):139-151.
[59]ZHANG L,LU SY,GUO R，et al.STK10 knockout inhibits cell migration and promotes cell proliferation via modulating the activity of ERM and p38 MAPK in prostate cancer cells［J］.Exp Ther Med，2021，22(2):851.
[60] CHEN XD，KHAJEH JAHAN ALI，JU JEONG HO，et al.Phosphatidylinositol 4,5-bisphosphate clusters the cell adhesion molecule CD44 and assembles a specific CD44-Ezrin heterocomplex，as revealed by small angle neutron scattering［J］.J Biol Chem，2015，290(10):6639-6652.
[61]WANG Y，LIN Z，SUN L，et al.Akt/Ezrin Tyr353/NF-κB pathway regulates EGF-induced EMT and metastasis in tongue squamous cell carcinoma［J］.Br J Cancer，2014，110(3):695-705.
[62]HSU YH，LIN WL，HOU YT，et al.Podocalyxin EBP50 ezrin molecular complex enhances the metastatic potential of renal cell carcinoma through recruiting Rac1 guanine nucleotide exchange factor ARHGEF7［J］.Am J Patho，2010，176(6):3050-3061.